Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

European journal of immunology - 1 Sept 1993

Houbiers J G, Nijman H W, van der Burg S H, Drijfhout J W, Kenemans P, van de Velde C J, Brand A, Momburg F, Kast W M, Melief C J

Abstract excerpt

The central role of the p53 tumor suppressor gene product in oncogenesis is gradually being clarified. Point mutations in the p53 tumor suppressor gene are common in most human cancers and are often associated with p53 protein overexpression. Overexpressed wild-type or mutant determinants of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Cell Line
Share to Cytotoxicity, Immunologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Sequence Data

Share to Mutation

Share to Structure-Activity Relationship

Share to T-Lymphocytes, Cytotoxic

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 8370389
DOI: 10.1002/eji.1830230905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-8370389-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.PMID 8370389Read ↗

A HLA-A2 restricted human CTL line recognizes a novel tumor cell expressed p53 epitope.Semantic proximity Read ↗

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53Semantic proximity Read ↗

Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant.Semantic proximity Read ↗

Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL line.Semantic proximity Read ↗

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.Semantic proximity Read ↗

Tolerance to p53 by A2.1-restricted Cytotoxic T LymphocytesSemantic proximity Read ↗

A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.Semantic proximity Read ↗

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide.Semantic proximity Read ↗

Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.Semantic proximity Read ↗

Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCRSemantic proximity Read ↗

Targeting p53 as a general tumor antigen.Semantic proximity Read ↗

Wildtype p53-specific antibody and T-cell responses in cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.